Quality of Life(QoL) in Korean Postmenopausal Osteoporosis Patients With Bisphosphonate Treatment

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01227369

Acronym

BRAVO

Enrollment

4376

Registered

2010-10-25

Start date

2008-06-30

Completion date

2009-11-30

Last updated

2017-06-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoporosis, Postmenopausal

Keywords

Bisphosphonates, OPSAT-Q

Brief summary

Quality of Life (QoL) in Korean postmenopausal osteoporosis patients with bisphosphonate treatment

Detailed description

Cross-sectional quality of life survey using self-administered OPSAT-QTM questionnaire in Korean postmenopausal osteoporosis patients with bisphosphonate treatment

Interventions

OTHEROPSAT-Q

A linguistically validated Korean version of OPSAT-Q

Study design

Observational model

OTHER

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

FEMALE

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Who have been diagnosed with postmenopausal osteoporosis by physician Who have received any oral bisphosphonates (weekly or monthly) at least for 2 months to provide answer of OPSAT-QTM questionnaire Who provide informed consent for study participation

Exclusion criteria

* Do not understand the contents of the questionnaire

Design outcomes

Primary

Measure	Time frame
Mean of composite satisfaction score (CSS) of OPSAT-QTM	0day

Secondary

Measure	Time frame
Mean of subscale satisfaction scores of OPSAT-QTM	oday

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026